What happened
Kyung NAM Pharm disclosed an acquisition of Ascendio, worth US$8.62M.
For context, this deal is worth about 8.4% of the company's own total assets.
| Target | Ascendio |
|---|---|
| Deal value | US$8.62M |
| vs. company assets | 8.4% |
| Filed | 2026-07-07, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260707900725 → open original filing |
Source: DART. Information only, not investment advice.